Petros Pharmaceuticals, Inc.

NASDAQ (USD): Petros Pharmaceuticals, Inc. (PTPI)

Last Price

0.14

Today's Change

-0.02 (12.50%)

Day's Change

0.132 - 0.15

Trading Volume

7,156,919

Overview

Market Cap

284,903

Shares Outstanding

2 Million

Avg Volume

6,677,351

Avg Price (50 Days)

1.35

Avg Price (200 Days)

6.23

PE Ratio

0.00

EPS

-83.50

Earnings Announcement

28-May-2025

Previous Close

0.16

Open

0.15

Day's Range

0.1321 - 0.15

Year Range

0.101 - 18.0

Trading Volume

8,599,239

Price Change Highlight

1 Day Change

-16.81%

5 Day Change

5.22%

1 Month Change

-87.32%

3 Month Change

-96.10%

6 Month Change

-97.97%

Ytd Change

-98.86%

1 Year Change

-99.15%

3 Year Change

-99.94%

5 Year Change

-99.99%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment